Quantum Dots Labeling & Conjugation Kits

With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announced the launch of its new Quantum Dots Labeling & Conjugation Kits with highly efficient and site-specific labeling and conjugation capabilities, including Biotin QDs Conjugation Kits, Covalent QDs Antibody Labeling Kits, QDs Cell Labeling Kits and Streptavidin QDs Conjugation Kits. Quantum dots (QDs) are semiconductor nanoparticles exhibiting size- and composition-dependent optical and electronic (photoelectronic) properties. They are extremely small, typically in the range of 1.5 to 10.0 nm. Recently, QD nanotechnology has been successfully introduced into numerous biomedical industries due to their unique properties, including excellent photostability, size-dependent optical properties, high extinction coefficient and brightness, and large Stokes shifts. CD Bioparticles has developed a comprehensive list of DiagNano™ semiconductor QDs with various chemical compositions and surface functionalizations. These quantum dots have demonstrated uniform dimensions, tunable emission, high quantum yield and good thermal stability, making them suitable for high-sensitivity cell imaging, photovoltaic devices, solar cells and light-emitting devices. To facilitate scientific research, CD Bioparticles now offers a range of quantum dots labeling and conjugation kits with highly efficient and site-specific labeling and conjugating capabilities, including Biotin QDs Conjugation Kits, Covalent QDs Antibody Labeling Kits, QDs Cell Labeling kits and Streptavidin QDs Conjugation Kits.